Every one of those 1 sits in a single category, markets. 329 Services is most often covered alongside Alto Neuroscience, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 3 original sources each against 2.4 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about 329 Services
Every one of those 1 sits in a single category, markets. 329 Services is most often covered alongside Alto Neuroscience, which appears in 1 of these 1 story. They are better corroborated than the beat average, carrying 3 original sources each against 2.4 for the same window. Their average consequence score of 6 runs below the beat's 6.2 for that window. We currently track 1 Finance story that mention 329 Services, all published on March 24, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 119 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering 329 Services. Shared-story counts are live from our verified record — not editorial picks.
Alto Neuroscience has successfully raised $120 million through a private placement, a significant capital injection aimed at accelerating its precision psychiatry platform. Led by CFO Nick Smith, the financing highlights growing investor confidence in biomarker-driven approaches to treating central nervous system (CNS) disorders.
329 Services is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.